Expanded newborn screening using tandem mass spectrometry: Two years' experience in Nuevo León, Mexico;Tamiz metabólico neonatal por espectrometría de masas en tándem: Dos años de experiencia en Nuevo León, México

Salud Publica de Mexico

Volumn 50, Issue 3, 2008, Pages 200-206

  Torres Sepúlveda, María Del Rosario ^a   Martínez de Villarreal, Laura E ^a,d   Esmer, Carmen ^a   González Alanís, Rogerio ^a   Ruiz Herrera, Consuelo ^a   Sánchez Peña, Alejandra ^a   Mendoza Cruz, José Alberto ^b   Villarreal Pérez, Jesús Z ^c  

^a UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

^b Servicios de Salud de Nuevo Leon   (Mexico)

^c HOSPITAL UNIVERSITARIO DR JOSÉ ELEUTERIO GONZÁLEZ   (Mexico)

^d Medicina UANL   (Mexico)

Author keywords

Developmental disabilities; Inborn errors of metabolism; Mental retardation; Metabolic neonatal screening; Mexico; Prevention

Indexed keywords

ARTICLE; HUMAN; INBORN ERROR OF METABOLISM; METHODOLOGY; MEXICO; NEWBORN; NEWBORN SCREENING; TANDEM MASS SPECTROMETRY; TIME;

HUMANS; INFANT, NEWBORN; METABOLISM, INBORN ERRORS; MEXICO; NEONATAL SCREENING; TANDEM MASS SPECTROMETRY; TIME FACTORS;

EID: 44349158367     PISSN: 00363634     EISSN: 16067916     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. MacCready RA, Hussey MG. Newborn phenylketonuria detection program in Massachusetts. Am J Pub Health 1964;54:2075-2081.
2. Guthrie R, Susi A. A simple phenyalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics 1963;32:338-343.
3. Wilson JMG, Jungner F. Principles and practice of screening for disease. Public Health Papers. Geneva: Switzerland: World Health Organization, 1968:34.
4. Guthrie R. Screening "Inborn errors of metabolism" in the newborn infant-a multiple test program. JAMA 1968;4:92-98.
5. Sweetman L. Newborn screening by tandem mass spectrometry (MS/ MS). Clin Chem 1996;42:345-346.
6. Millington DS, Norwood DL, Kodo N. Application of fast atom bombardment with tandem mass spectrometry and liquid chromatography/mass spectrometry to the analysis of acylcarnitines in human urine, blood and tissue. Anal Biochem 1989;180:331-339.
7. Rashed MS, Ozand PT, Bucknall DN. Diagnosis of inborn errors of metabolism from blood spots by acylcarnitines and amino acids profiling using automated electrospray tandem mass spectrometry. Pediatr Res 1995;38:324-331.
8. Hunt DF, Giordani ABB, Rhodes G, Herold DA. Mixture analysis by triple quadrupole mass spectrometry: metabolic profiling of urinary carboxylic acids. Clin Chem 1982;28:2387-2392.
9. Chace DH, Kalas TA. A biochemical perspective on the use of tandem mass spectrometry for newborn screening and clinical testing. Clin Biochem 2005;38:296-309.
10. Chace D. Use of tandem mass spectrometry for multianalyte screening of dried blood specimens from newborns. Clin Chem 2003;49(11):1797-1817.
11. Willey V, Carpenter K, Wilcken B. Newborn screening with tandem mass spectrometry: 12 months' experience in NSW Australia. Acta Paediatr 1999;(suppl 88):48-51.
12. Simonsen H, Jensen UG. Technical aspects of neonatal screening using tandem mass spectrometry. Report for 4th Meeting of the International Society for Neonatal Screening. Acta Paediatr 1999;432:52-54.
13. Velázquez A, Loera A, Aguirre BE, Gamboa S, Vargas H, Robles C. Tamiz neonatal para hipotiroidismo congénito y fenilcetonuria. Salud Publica Mex 1994;36:249-256.
14. Ibarra I, Fernández C, Belmont L, Vela M. Elevada mortalidad y discapacidad en niños mexicanos con enfermedad de orina de jarabe de arce (EOJA). Gac Med Mex 2007;143(3):197-201.
15. Norma Oficial Mexicana NOM-034-SSA2-2002. Para la prevención y control de los defectos al nacimiento. Diario Oficial de la Federación, México DF, lunes 23 de octubre de 2003.
16. Millington D, Koeberl D. Metabolic screening in the newborn. GGH 2003;19(3):33-38.
17. Chace DH, Sherwin JE, Hillman S, Lorey F, Cunningham GC. Use of phenylalanine to tirosine ratio determined by tandem mass spectrometry to improve newborn screening for phenylketonuria of early discharge specimens collected in the first 24 hours. Clin Chem 1998;44:2405-2409.
18. Sweetman L. Newborn screening by tandem mass spectrometry: gaining experience. Clin Chem 2001;47:1937-1938.
19. Kaye CI. Introduction to the newborn screening. Fact Sheets. Pediatrics 2006;118:1304-1312.
20. Rashed M. Clinical applications of tandem mass spectrometry: ten years of diagnosis and screening for inherited metabolic diseases. J Chromatogr B 2001;758:27-48.
21. Webster D, Dhondt JL, Hannon WH, Loeber G, Torresani T. Quality assurance and standardization: summary of the satellite meeting, Turku, Finland. Acta Paediatr 1999;(suppl 88):7-12.
22. Chace DH. Mass spectrometry in the clinical laboratory. Chem Rev 2001;101:445-477.